| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS SyndromePayerPolicy · BCBSMS-A-8-01-17-9223816B65 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Non-Hodgkin LymphomasPayerPolicy · BCBSMS-A-8-01-20-B73556F792 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in AdultsPayerPolicy · BCBSMS-A-8-01-24-D52CBFDE03 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · BCBSMS-A-8-01-29-E3B4E14CAB | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Epithelial Ovarian CancerPayerPolicy · BCBSMS-A-8-01-23-420E71F813 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for CNS Embryonal Tumors and EpendymomaPayerPolicy · BCBSMS-A-8-01-28-C773E3C472 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Chronic Myeloid LeukemiaPayerPolicy · BCBSMS-A-8-01-30-848142085E | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPayerPolicy · BCBSMS-A-8-01-15-738A961346 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Autoimmune DiseasesPayerPolicy · BCBSMS-A-8-01-25-DAD0C9DF6E | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaPayerPolicy · BCBSMS-A-8-01-26-C47BD33EA1 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaPayerPolicy · BCBSMS-A-8-01-32-290F02CEAE | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Heavy Metal TestingPayerPolicy · BCBSMS-L-2-04-417-1AD73748DC | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Heart/Lung TransplantPayerPolicy · BCBSMS-A-7-03-08-67D87EE3B8 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Heart TransplantPayerPolicy · BCBSMS-A-7-03-09-B80A825A20 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Healthy You! Wellness ProceduresPayerPolicy · BCBSMS-L-2-01-406-CB493B9D06 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving SurgeryPayerPolicy · BCBSMS-A-7-01-140-37D5F5928F | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | H-Wave Electrical StimulationPayerPolicy · BCBSMS-L-1-01-410-5607507078 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Grenz Ray Therapy for Skin DisordersPayerPolicy · BCBSMS-L-8-01-402-A51E8CD030 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | GLP-1 AgonistPayerPolicy · BCBSMS-L-5-01-428-FAB47CA451 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Givlaari (givosiran)PayerPolicy · BCBSMS-L-5-01-553-EF6BCF8E82 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Giant Cell ArteritisPayerPolicy · BCBSMS-L-5-01-516-9B96272435 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Germline Genetic Testing for Pancreatic Cancer Susceptibility Genes (ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, STK11, and TP53)PayerPolicy · BCBSMS-A-2-04-148-8115C66CD9 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Germline Genetic Testing for Hereditary Diffuse Gastric Cancer (CDH1, CTNNA1)PayerPolicy · BCBSMS-A-2-04-154-8867A4F801 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Germline Genetic Testing for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers (BRCA1, BRCA2, PALB2)PayerPolicy · BCBSMS-A-2-04-02-F876CA23A6 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Germline Genetic Testing for Gene Variants Associated With Breast Cancer in Individuals at High Breast Cancer Risk (CHEK2, ATM, and BARD1)PayerPolicy · BCBSMS-A-2-04-126-72580C67FF | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Germline Genetic Testing for Familial Cutaneous Malignant Melanoma (CDKN2A, CDK4)PayerPolicy · BCBSMS-A-2-04-44-8277CF25B1 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Prostate Cancer (BRCA1/2, Homologous Recombination Repair Gene Alterations, NTRK Gene Fusion)PayerPolicy · BCBSMS-A-2-04-155-9F10F55CE9 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Ovarian Cancer (BRCA1, BRCA2, Homologous Recombination Deficiency, NTRK)PayerPolicy · BCBSMS-A-2-04-156-0885A81941 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Breast Cancer (BRCA1, BRCA2, PIK3CA, Ki-67, RET, BRAF, ESR1, NTRK)PayerPolicy · BCBSMS-A-2-04-151-7760F8E956 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | GepantsPayerPolicy · BCBSMS-L-5-01-566-B56EA612BE | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genotyping for 9p21 Single Nucleotide Polymorphisms to Predict Risk of Cardiovascular Disease or AneurysmPayerPolicy · BCBSMS-L-2-04-430-B2C8E7C417 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genotype-Guided Warfarin DosingPayerPolicy · BCBSMS-A-2-04-48-C9C95A4EB3 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genotype-Guided Tamoxifen TreatmentPayerPolicy · BCBSMS-L-2-04-464-AE27962C69 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Rett SyndromePayerPolicy · BCBSMS-L-2-04-461-9704F2E713 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for PTEN Hamartoma Tumor SyndromePayerPolicy · BCBSMS-A-2-04-88-8E634EBE0B | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Predisposition to Inherited Hypertrophic CardiomyopathyPayerPolicy · BCBSMS-A-2-02-28-B52C5ADA50 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for NeurofibromatosisPayerPolicy · BCBSMS-A-2-04-137-38F0E1BD5A | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Mitochondrial DisordersPayerPolicy · BCBSMS-A-2-04-117-3AC46F4D35 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Macular DegenerationPayerPolicy · BCBSMS-A-2-04-103-BA399B4F78 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer SyndromesPayerPolicy · BCBSMS-A-2-04-08-E4EA31341C | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin TreatmentPayerPolicy · BCBSMS-L-2-04-454-1599E6808B | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Limb-Girdle Muscular DystrophiesPayerPolicy · BCBSMS-L-2-04-459-3D07660091 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Li-Fraumeni SyndromePayerPolicy · BCBSMS-A-2-04-101-1DB817BC83 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Lactase InsufficiencyPayerPolicy · BCBSMS-L-2-04-462-E31AD7BC88 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Inherited ThrombophiliaPayerPolicy · BCBSMS-A-2-04-82-6C7B6F904A | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Idiopathic Dilated CardiomyopathyPayerPolicy · BCBSMS-A-2-04-114-42CA864FE8 | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Hereditary HemochromatosisPayerPolicy · BCBSMS-L-2-04-460-C76F8D1F8C | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for Helicobacter Pylori TreatmentPayerPolicy · BCBSMS-L-2-04-428-29DC3DD6CE | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for FMR1 Variants (including Fragile X Syndrome)PayerPolicy · BCBSMS-A-2-04-83-7E72F2FC1F | New policy |
|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Genetic Testing for FLT3, NPM1, CEBPA, IDH1, and IDH2 Variants in Cytogenetically Normal Acute Myeloid LeukemiaPayerPolicy · BCBSMS-A-2-04-124-FCD6A93F62 | New policy |
|---|